Weight Loss
Q&A: Physicians encouraged to ease guilt, embarrassment in patients with obesity
A new poll suggests the COVID-19 pandemic may have exacerbated the obesity epidemic in the United States.
Endoscopic sleeve gastroplasty may be safe for managing weight loss in NASH
Endoscopic sleeve gastroplasty in patients with nonalcoholic steatohepatitis vs. life-style intervention alone was safe and effective for achieving weight loss correlated with significant improvements, according to a presentation at the International Liver Congress.
Pramlintide-insulin co-formulation improves time in range in type 1 diabetes
ADO09, a co-formulation of pramlintide and insulin A21G, was associated with better glucose levels, improved time in range and more weight loss among people with type 1 diabetes compared with insulin aspart, according to a presenter.
SURPASS data: ‘Impressive’ tirzepatide could change goals for diabetes treatment
Data from the SURPASS clinical trial program suggest the dual incretin agonist tirzepatide could be a game-changing new therapy for adults with type 2 diabetes, many of whom experienced substantial weight loss and achieved normoglycemia.
Microbiome-based diet may improve metabolic markers in early type 2 diabetes
An algorithm-based, personalized diet based on gut microbiome features and clinical data may improve glycemic response and other metabolic parameters for adults with newly diagnosed type 2 diabetes, data show.
SURPASS-2: Tirzepatide bests semaglutide in HbA1c reduction, weight loss
The investigational glucose-dependent insulinotropic polypeptide/GLP-1 receptor agonist tirzepatide led to significant and superior HbA1c and body weight reductions for adults with type 2 diabetes vs. semaglutide, SURPASS-2 study data show.
Hydrogel capsule for weight loss may reduce risk for liver fibrosis
An oral hydrogel capsule for treatment of obesity may reduce liver fibrosis risk, according to an exploratory analysis of the GLOW study presented at the American Association of Clinical Endocrinology annual meeting.
Low-calorie diet may effectively ‘replace’ BP medications in type 2 diabetes
Replacing antihypertensive medications with a low-calorie diet to induce weight loss substantially reduces blood pressure and may increase mild dizziness for adults with type 2 diabetes, according to a post hoc analysis of the DiRECT study.
FDA approves once-weekly semaglutide for weight loss
The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.
FDA approves once-weekly semaglutide for weight loss
The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.